- Home
- GOGL vs TMDX Comparison
GOGL vs TMDX Comparison
Compare GOGL & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOGL
- TMDX
- Stock Information
- Founded
- GOGL N/A
- TMDX 1998
- Country
- GOGL Bermuda
- TMDX United States
- Employees
- GOGL N/A
- TMDX N/A
- Industry
- GOGL Marine Transportation
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GOGL Consumer Discretionary
- TMDX Health Care
- Exchange
- GOGL Nasdaq
- TMDX Nasdaq
- Market Cap
- GOGL 1.8B
- TMDX 2.1B
- IPO Year
- GOGL 1997
- TMDX 2019
- Fundamental
- Price
- GOGL $8.86
- TMDX $57.20
- Analyst Decision
- GOGL Hold
- TMDX Buy
- Analyst Count
- GOGL 2
- TMDX 11
- Target Price
- GOGL $12.25
- TMDX $116.10
- AVG Volume (30 Days)
- GOGL 1.4M
- TMDX 2.6M
- Earning Date
- GOGL 02-28-2025
- TMDX 02-24-2025
- Dividend Yield
- GOGL 13.54%
- TMDX N/A
- EPS Growth
- GOGL 102.13
- TMDX N/A
- EPS
- GOGL 1.22
- TMDX 0.94
- Revenue
- GOGL $1,011,652,000.00
- TMDX $401,090,000.00
- Revenue This Year
- GOGL N/A
- TMDX $81.61
- Revenue Next Year
- GOGL $2.75
- TMDX $22.52
- P/E Ratio
- GOGL $7.27
- TMDX $61.04
- Revenue Growth
- GOGL 14.81
- TMDX 109.09
- 52 Week Low
- GOGL $8.52
- TMDX $56.03
- 52 Week High
- GOGL $15.77
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- GOGL 39.47
- TMDX 35.74
- Support Level
- GOGL $9.07
- TMDX $58.40
- Resistance Level
- GOGL $9.52
- TMDX $67.80
- Average True Range (ATR)
- GOGL 0.22
- TMDX 4.59
- MACD
- GOGL 0.07
- TMDX -0.27
- Stochastic Oscillator
- GOGL 18.52
- TMDX 4.44
About GOGL Golden Ocean Group Limited
Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.